Login to Your Account

FDA 'Nucs' Idenix with '963 Safety Data Request

By Marie Powers
Staff Writer

Friday, June 21, 2013
Idenix Pharmaceuticals Inc. suffered yet another blow in the development of its hepatitis C virus (HCV) drug pipeline, as the FDA requested additional preclinical safety data for IDX20963 ('963), the company's lead uridine nucleotide prodrug.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription